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We examined 14 different feline leukemia virus proviruses from the productively
infected human cell line RD(FeLV)-2 after cloning in the modified lambda vector
Charon 4A. Each isolate was characterized by restriction digestion and Southem
blot analysis. The DNA of each isolate was tested for competence to express virus
after uptake by sensitive animal cells (transfection). All but one isolate contained
an apparently complete provirus, but only four were infectious. Seven isolates
(four noninfectious, three infectious) were studied by heteroduplexing followed
by electron microscopy or by S1 nuclease treatment and gel electrophoresis. No
regions ofnonhomology between proviruses were detected by either criterion, and
in no case did we observe homology between flanking sequences. Random shearing
or removal of flanking sequences by S1 nuclease had no effect on the status of
infectivity of the clones. Thus, we were unable to find molecular differences
between infectious and noninfectious proviruses. Our data are consistent with
either of the following hypotheses: (i) that there is a short host sequence which
is essential as a promoter for virus expression; or (ii) that lack of infectivity is due
to small mutations within the proviral genome.
Upon infection, the single-stranded RNA ge-
nome of a retrovirus is copied by reverse tran-
scription into an unintegrated linear double-
stranded DNA copy (47). The latter contains all
of the sequences of the RNA in a nonpermuted
order. Furthermore, long terminal repeats
(LTRs), which are made up ofsequences derived
from both the 5' end and the 3' end of the viral
RNA, are found at both ends. Subsequently, one
or several copies of the viral genome become
integrated into the chromosomal DNA of the
host cell (provirus formation). In several cases
where a number of independently infected cell
lines have been studied, no evidence for pre-
ferred integration sites has been found (47).
In virus-productive cells, at least one provirus
is actively transcribed, resulting ultimately in
the release of virus by the cells. For cases where
multiple integration has occurred, it is not
known how many of the integrated viral ge-
nomes are actually transcribed.
When sensitive cells are exposed under the
appropriate conditions to chromosomal DNA
from cells expressing viral information, some
proviral DNA is taken up; if expressed, this
proviral DNA is referred to as infectious (6, 17,
19, 30). This process is called transfection. In
some cases, virus expression results in horizontal
spread of the virus through the culture by the
normal route of infection, so that many of the
cells acquire integrated viral genomes and be-
come virus productive. In general, it has been
observed that the DNA from cells which pro-
duce a high titer of virus is infectious, whereas
the DNA from cells which produce a low titer of
virus or no detectable virus is not infectious (7,
28, 31).
In some cases, cells in the latter category
contain complete viral infonnation, as shown by
the low level of virus expression which occurs or
can be induced by treating the cells with the
halogenated pyrimidines bromodeoxyuridine
and iododeoxyuridine (7, 38). These observa-
tions support the hypothesis that an integrated
viral genome in a configuration in which it is
being expressed at a relatively high rate is infec-
tious, whereas integrated viral genomes which
are not being expressed at a high rate are not.
At present however, the molecular nature of the
difference or differences between integrated
viral genomes that are infectious and those that
are not is not known.
Feline leukemia virus (FeLV) is a particularly
interesting retrovirus because it is an infectious
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agent which causes leukemia in cats in nature.
About one-third of the naturally occurring
lymphoid tumors in domestic cats do not contain
infectious FeLV or viral structural proteins (13,
22, 43), yet epidemiological evidence suggests
that virus-negative tumors are associated with
exposure to FeLV (16a; D. P. Francis, M. Essex,
S. M. Cotter, N. Gutensohn, R. Jakowski, and
W. D. Hardy, Jr., Cancer Lett., in press). It is
not known whether the DNAs of virus-negative
tumors possess complete viral information. Fur-
thermore, the genomes of healthy domestic cats
that are believed to be uninfected contain FeLV
cross-hybridizing sequences. There is evidence
that some portion of the infectious genome is
not present in these endogenous sequences (32).
Several natural FeLV isolates have been de-
scribed, and these fall into three subgroups (sub-
groups A, B, and C), based on viral interference
(35, 36). Restriction maps have been deduced
for two subgroup B isolates, namely, Snyder-
Theilen FeLV (ST-FeLV) (mapped by Sherr
and co-workers [42]) and Gardner-Arnstein
FeLV (GA-FeLV) (mapped in our laboratory
[29]). There is significant homology between
these two isolates, as determined by a Southern
blot analysis (Mullins, unpublished data) and by
a comparison of restriction maps. For the 10
enzymes common to both studies, 12 sites map
to comparable regions of the two genomes,
whereas 10 sites are unique to the ST-FeLV-B
genome and 1 site is unique to the GA-FeLV-B
genome. Also notable is the fact that although
the overall length of the ST-FeLV-B genome is
about 0.2 kilobase (kb) shorter than the GA-
FeLV-B genome, the ST-FeLV-B LTRs are
about 0.2 kb longer and contain EcoRI sites
which are absent in GA-FeLV-B DNA.
In a previous study, we presented a restriction
endonuclease map of the unintegrated linear
viral DNA isolated from human cells (RD)
freshly infected with GA-FeLV (29). RD(FeLV)-
2 is a cloned, virus-productive cell line derived
from such an infection. It contains approxi-
mately 8 to 10 copies of integrated FeLV per
haploid genome, as estimated by blot hybridi-
zation intensity (25; Mullins, unpublished data).
This corresponds to 16 to 20 different viral in-
tegrations per cell, since Southern blotting data
has demonstrated that proviruses are not de-
tected in each homologous chromosomal site in
these cells (Mullins, unpublished data). The re-
striction digestion patterns of these integrated
viral genomes were also characterized in a pre-
vious study (29).
Some of our long-term goals are to determine
whether there are acquired FeLV sequences in
virus-negative leukemic cats and to characterize
and compare such sequences with the acquired
sequences in virus-productive leukemic cats and
with the endogenous FeLV sequences in all cats.
Another goal is to determine the molecular na-
ture of the differences between integrated viral
genomes that are infectious and those that are
not. As a first step, we have cloned and carried
out an initial characterization of some of the
integrated viral genomes of the RD(FeLV)-2 cell
line.
MATERIALS AND METHODS
RD(FeLV)-2 cells. The RD(FeLV)-2 cell line was
derived by soft agar cloning of RD cells 40 passages
after mass infection with GA-FeLV-B. DNA from
passage 14 after cell cloning was used in subsequent
recombinant DNA experiments.
Preparations of RD(FeLV)-2 and Charon 4A
DNAs for cloning. RD(FeLV)-2 DNA was purified
as previously described (29). EcoRI digestion and su-
crose gradient fractionation were performed by the
procedures described by Maniatis et al. (26). Fractions
containing 8- to 25-kb DNA were identified by gel
electrophoresis, pooled, and concentrated by ethanol
precipitation.
Charon 4A was propagated on KH802 cells (2) by
subconfluent plate lysis in Pyrex dishes (18 by 30 cm);
107 PFU of Charon 4A and 1010 KH802 cells were
incubated in 1 ml of SM (50 mM Tris-hydrochloride,
pH 7.5, 0.1 M sodium chloride, 5 mM magnesium
sulfate, 0.01% gelatin) at 37°C for 15 min and then
plated along with a 25-ml top layer of 3X medium (3%
NZ amine [Humko-Sheffield], 0.3% Casamino Acids,
0.5% sodium chloride, 1.5% yeast extract, 0.004% thy-
midine, 0.01% diaminopimelic acid, 0.12% magnesium
sulfate) containing 0.6% agar. The bottom layer con-
sisted of 250 ml of 3X medium containing 1.5% agar.
After 14 to 18 h at 370C, top layers were scraped off
and extracted with 25 ml of SM containing 1% chlo-
roform. Agar was removed by centrifugation at 7,000
x g for 10 min. Phage and phage DNA were purified
by the methods of Tiemeier et al. (45). The yields of
phage DNA grown by this method ranged between
150 and 600 ,ug/dish.
EcoRI-digested phage arms were prepared and li-
gation of phage arms and size-selected RD(FeLV)-2
DNA was carried out by the procedures described by
Maniatis et al. (26).
Preparation ofin vitro packaging extracts. We
used the lysogenic bacterial strains NS428 and NS433
(44) and a modification of the procedures of Hohn and
Murray (19) and Collins and Hohn (4) to prepare in
vitro packaging extracts, as described below.
The presence of heat-inducible lysogens was veri-
fied by plating onto M9 medium plates (44) at 42°C
(no growth) and 32°C. Overnight cultures were begun
from colonies grown at 32°C; subsequently, 500-ml
cultures were inoculated with 5 ml of a stationary-
phase culture and grown with shaking at 32°C until
an absorbance at 600 nm of 0.3 to 0.4 was reached.
Lysogens were then induced by placing cultures in a
450C water bath for 15 min and swirling occasionally.
Induced cultures were grown at 37°C for an additional
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2 h with vigorous aeration. Cultures were then mixed
at a ratio of NS433 to NS428 of 2:1 and chilled in an
ice water bath, and the cells were pelleted by centrif-
ugation at 7,000 x g for 10 min at 40C. The cells were
then suspended in 0.2 volume of M9 medium without
Casamino Acids and irradiated as described by Man-
iatis et al. (26). The cells were then pelleted as de-
scribed above, the supernatant was removed by decan-
tation, and the remaining liquid was removed with a
pipette. Subsequent steps were carried out quickly at
4°C. 0.004 volume of packaging buffer (40 mM Tris-
hydrochloride, pH 8.0, 10 mM spermidine hydrochlo-
ride, 10 mM putrescine hydrochloride, 0.1% ,3-mercap-
toethanol, 7.0% dimethyl sulfoxide, 1.5 mM ATP) was
stirred into the cell pellet thoroughly, and 50-,ul por-
tions were placed into 1.5-ml snap cap polypropylene
tubes and immediately frozen in liquid nitrogen. Ex-
tracts can be stored at -70 to -80°C for at least 1 year
without loss of activity but cannot be allowed to thaw
before use.
In experiments conducted since the 1980 change in
the National Institutes of Health guidelines, the UV
irradiation step was omitted. However, background
phage due to packaging of lysogens was effectively
zero if the in vitro-packaged phage were grown initially
on a Sup III host, such as KH802.
Packaging reaction. Extracts were placed in an
ice water bath for about 2 min. While thawing, 6 Ad of
a solution containing 20 mM ATP and DNA (in liga-
tion buffer) was added and stirred in well, and the
mixture was incubated at 370C for 60 min. To a second
extract 5 pl of DNase I (100ltg/ml; Worthington
Diagnostics) in 0.25 M magnesium chloride was added
and stirred in well, and the mixture was left on ice for
5 min; 20 Il of the DNase-treated extract was added
to the reaction and mixed in weUl, and this mixture was
incubated at 370C for 30 min. At the end of the
reaction, 0.5 ml of SM was added, followed by the
addition of 2 drops of chloroform. The reaction mix-
ture was stirred, centrifuged for 10 s, and finally stored
at 40C. When preparations were stored in this way,
phage titers decreased roughly about 1 order of mag-
nitude during the first 1 year of storage.
It has been found (D. Goldberg and E. Fritsch,
personal communication) that higher packaging effi-
ciencies could be obtained for some preparations in
more dilute reactions. We now test each preparation
of extracts for optimal efficiency with between 0 and
30 pd of additional packaging buffer. In our hands,
packaging efficiencies range between 0.7 x 106 and 1
X 107 PFU/,ug of inserted DNA. Efficiencies for uncut
vector DNAs are usually about 10-fold higher.
Library amplification and screening. All recom-
binant phage were grown on DP50 SupF cells. Ampli-
fication was performed as described by Maniatis et al.
(26), using 3X medium plates.
Screening was conducted by in situ plaque hybrid-
ization on plates containing NZCY/DTM medium (1%
NZ amine, 0.5% sodium chloride, 0.5% yeast extract,
0.1% Casamino Acids, 0.01% diaminopimelic acid,
0.004% thymidine, 1.2% magnesium sulfate) (1). Ab-
sorption of phage and phage DNA to nitrocellulose
filters was conducted as described by Maniatis et al.
(26). Subsequently, filters were dipped into 0.5 M
sodium hydroxide-0.8 M sodium chloride for 30 to
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60 s and neutralized by dipping into two changes of
0.5 M Tris-hydrochloride (pH 7.6)-1.5 M sodium chlo-
ride (60 s each). After air drying, filters were baked in
vacuo at 70°C for 2 to 4 h. Filters were washed with
mild rubbing in three or four 500-mil changes of 4x
SET (lx SET is 0.15 M sodium chloride, 0.03 M Tris-
hydrochloride [pH 8], 2 mM EDTA) at room temper-
ature and then equilibrated in 4X SET containing 50%
formamide. The procedures used for pre-hybridiza-
tion, hybridization (with 10% dextran sulfate; 32P-la-
beled FeLV complementary DNA probe concentra-
tion, 106 cpm/ml or 1.2 ng/ml), washing, and exposure
to X-ray film have been described previously (29).
FeLV-containing phage were purified by re-
screening (26) once or twice and subsequent analysis
of individual plaques (see below).
Growth and analysis of recombinant DNA
clones. Phage stocks of purified recombinant phage
(1 x 1010 to 7 x 1010 PFU/ml) were each obtained by
inoculating 100 pi of a stationary-phase culture of
DP50 Sup F with a phage plug, diluting into 1 ml of
fresh medium, and growing overnight at 370C. Chlo-
roform was added, cell debris was removed by centrif-
ugation, and the stock was stored over chloroform at
40C.
DNA from each isolate was obtained initially by a
slight modification of the miniplate lysis procedure of
Davis and co-workers (9). In this procedure, 105 PFU
of Charon 4A and 10' DP50 SupF cells were mixed
and incubated at 370C for 15 min and then plated onto
100-mm NZCY/DTM medium plates, using 0.6% top
layer agarose and 1.2% bottom layer agarose to replace
the agar. When nearly confluent lysis was achieved
(10 to 12 h), the plates were cooled to 40C for 0.5 hour;
5 ml of chloroform-saturated 10 mM Tris (pH 7.6)-2
mM magnesium chloride was added to cover the top
layer, and the plates were stored at 40C overnight. A
4-ml portion of eluate was added to a solution contain-
ing 0.4 mil of 0.5 M EDTA (pH 8.5), 0.2 ml of 2 M Tris
(pH 9.7), and 0.2 mil of 10% sodium dodecyl sulfate,
and the mixture was blended briefly with a Vortex
mixer. A 10-pl portion of diethyl oxydiformate was
added, and tubes were incubated at 650C for 30 min
with occasional swirling. The tubes were then chilled
on ice, 1 ml of 5 M potassium acetate was added and
mixed in, and the mixtures were allowed to stand on
ice for 1 h. Precipitates were removed by centrifuga-
tion at 20,000 x g for 20 min, and the supernatants
were decanted carefully into centrifuge tubes contain-
ing 10.5 ml of cold 95% ethanol. Tubes were chilled at
-20 or -70°C, and precipitates were recovered by
centrifugation at 20,000 x g for 30 min. Pellets were
dried and then suspended and stored frozen in 200 pl
of TLE (10 mM Tris, pH 7.8, 0.1 mM EDTA); 5 to 15
pl was used per restriction digest, along with about 2
to 5 U of enzyme.
Large-scale preparations of phage and phage DNA
were made by the procedures described above for
Charon 4A. Some phage were also grown by the liquid
culture procedure described by Blattner et al. (2).
Restriction endonuclease analysis. The proce-
dures used for restriction digestion, gel electrophoresis,
Southern blotting, FeLV complementary DNA syn-
thesis, and hybridization were as previously described
(29). Nick-translated probes were prepared by a mod-
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ification of the procedure of Maniatis et al. (27). Each
reaction mixture contained 10 pg ofDNA per ml, 5 pM
[nP]dCTP (410 Ci/mmol; Amersham), 10 pm dATP,
10 IpM dGTP, 10pFM TTP, 1 ng ofDNase I (Boehringer
Mannheim Corp.) per ml, and 20 U of DNA polymer-
ase I (Boehringer Mannheim) per ml in a solution
containing 50 mM Tris-hydrochloride (pH 7.8), 5 mM
magnesium chloride, 5 mM dithiothreitol, 50 pg of
bovine serum albumin (Pentex, Miles Biochemical)
per ml, and 5% glycerol. The reaction mixture was
cooled on ice before the addition of enzymes and then
incubated at 15°C for 1 to 2 h; 1 volume of column
elution buffer (50 mM Tris-hydrochloride, pH 7.5, 250
mM sodium chloride, 0.2% sodium dodecyl sulfate 2
mM EDTA) was added, and unincorporated nucleo-
tides were removed by chromatography on Sephadex
G-50 (fine). AU hybridizations were done for 17 to 20
h; we used 5 x 104 dpm (0.06 ng) of 3P-labeled FeLV
complementary cDNA per ml for restriction mapping,
1 x 106 dpm (1.2 ng) of 3P-labeled FeLV complemen-
tary DNA (10% dextran sulfate) per ml DNA for
analysis of Sl-treated heteroduplexes, 6 x 105 dpm (20
ng) of 3P-labeled Alu family DNA per ml, and 2.5 x
106 dpm (50 ng) of 3P-labeled RD DNA per ml as
probes.
Electron microscopy. Heteroduplexes were con-
structed and spread for electron microscopy by using
purified phage, as described by Davis et al. (8). Mole-
cules were examined with a Philips EM 300 electron
microscope and photographed with 35-mm film. Neg-
atives were projected onto a table, and images were
measured with a Hewlett-Packard digitizer.
Biological analysis. The procedures used for
transfection and reverse transcriptase assay have been
described previously (30). Complement fixation assays
(14) were conducted in the laboratory of R. V. Gilden,
Frederick Cancer Research Center. Virus interference
assays (21) were conducted in the laboratory of 0.
Jarrett, University of Glasgow.
Si nuclease digestion of heteroduplexes. Two
XHF clone DNAs (2 ug of each) were mixed and
denatured in 60% formamide in TLE at 50°C for 5 min
in a volume of45 p1. The reaction mixture was adjusted
to 0.4 M sodium chloride, 50 mM Tris-hydrochloride
(pH 8.1), and 2 mM EDTA in a total volume of 50 ,l
and then incubated at 37°C for 10 min; 1 ml of NTE
(0.1 M sodium chloride, 10mM Tris-hydrochloride pH
7.8, 1 mM EDTA) and 2.8 ml of 95% ethanol were
added, and the mixture was chilled at -20°C. Precip-
itates were collected by centrifugation at 10,000 x g
for 5 mi.
S1 nuclease digestion was performed by a procedure
similar to procedures described previously (40, 41).
Ethanol precipitates were dissolved in 35 pl of 30 mM
Tris-acetate (pH 4.5)-200 mM sodium chloride-3 mM
zinc sulfate and digested with 50 U of Si nuclease
(Boehringer Mannheim) at 25-C for 15 min. The
amount of S1 nuclease and the conditions of digestion
used were such that a similar quantity of closed cir-
cular OX174 DNA was converted into a 1:1 mixture of
nicked circular and linear molecules. EDTA was then
added (final concentration, 10 mM), and samples were
loaded directly onto gels; 8.7 kb of S1 nuclease-treated
heteroduplex DNA was purified from the gels, as
described previously (3).
RESULTS
Cloning integrated FeLV DNA in Charon
4A. The GA-FeLV genome contains no EcoRI
endonuclease sites. Electrophoretic fractiona-
tion of EcoRI digests of RD(FeLV)-2 DNA has
shown FeLV hybridizing sequences present as a
number of discrete bands in the 8- to 25-kb range
(29). As Table 1 shows, RD(FeLV)-2 chromo-
somal DNA was infectious by transfection, and
EcoRI digestion did not alter this infectivity.
The 8- to 25-kb fraction isolated by sucrose
gradient fractionation was infectious at the same
level as the undigested DNA.
The cloning capacity of the modified lambda
cloning vector Charon 4A is approximately 8 to
22 kb (2). Therefore, we cloned EcoRI-digested
and size-fractionated RD(FeLV)-2 DNA into the
purified end fragments of EcoRI-digested
Charon 4A DNA by ligation and in vitro pack-
aging, as described above. A total of 3 x 105
recombinant phage were amplified by subcon-
fluent plate lysis, replated, and screened with an
FeLV probe. Another 8 x 104 phage were
screened without prior amplification to insure
that the cloned FeLV isolates were independ-
ently ligated and packaged before growth in
Escherichia coli. A total of 60 FeLV-positive
clones were picked from the amplified phage
preparation (clones XHF1 through XHF60), and
12 more were picked from the unamplified prep-
aration (clones XHF61 through XHF72). We pur-
ified and studied the DNA from 27 clones by
restriction mapping, Southern blotting, and
transfection.
The restriction map of the proviral genome is
shown in Fig. 1. There was a single SmaI site
within each LTR, and there were three addi-
tional SmaI sites in the interior of the genome.
These sites defined four electrophoretic bands
that were within viral sequences and independ-
TABLE 1. Transfection with RD(FeL V)-2 DNA
Sample Treatment Infectivity-
RD(FeLV)-2 None +b
RD(FeLV)-2 EcoRI digestion +
RD(FeLV)-2 EcoRI digestion and +
(8 to 25 kb) sucrose gradient
fractionation
a Assays for virus infectivity are described in Table
3, footnotes. Dog D-17 cells were used to test all DNA
samples. Positive cultures (those producing extracel-
lular reverse transcriptase [30]) were assayed by the
complement fixation test and were found to contain
FeLV p30. Virus from positive cultures was used to
infect cat embryo AH927 cells and was found to con-
tain FeLV subgroup B by virus interference tests (21).
bA 1-pg amount of each RD(FeLV)-2 DNA was
needed to detect virus production.
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FIG. 1. Restriction maps of EcoRI insertions in seven provirus clones. Each isolate had the same pattern
of sites within the FeLVprovirus region. These sites are shown at the top. The positions of the 5' and 3' ends
of the provirus are as predicted from unintegrated linear viral DNA mapping (29). Additional sequences
extending from the SmaI site at the 5' end of the provirus and from the KpnI site at the 3' end are indicated
in the lower diagrams. AL and AR refer to the positions of the left (19.8-kb) and right (10.9-kb) vector arms,
respectively, relative to the insert in each clone. Restriction sites were mapped after digestion with the enzyme
indicated alone or with either XhOI or EcoRI. Other double digestions were used to map sites which could
not be positioned using Xho I or EcoRI combinations. Additional PstI sites were present in the flanking
sequences ofsome clones but were not mapped. The underlined regions in the maps of isolates AHF1 7, AHF52,
XHF49, and XHF39 correspond to restriction fragments which hybridized to an Alu family repeated sequence
probe (see Fig. 3). Alu repeats were found on three or four fragments 5' to the FeLV provirus in AHF49;
however, not all of these repeats could be assigned to a given fragment, and therefore all four fragments are
underlined (see legend to Fig. 3). The underlined region in the map of isolate AHF8 corresponds to an
additional repeated sequence element identified by hybridization when total RD DNA was used as the probe
(see Fig. 3).
ent of enzyme sites in flanking host sequences.
All of these bands were present in all of the
cloned isolates. Similarly, there were four KpnI
sites in the viral genome, two of which were in
the LTRs. All of the cloned isolates except
XHF62 contained the four KpnI sites. AHF62
was missing the KpnI site in the left LTR, but
a new site was present at a position 200 base
pairs 5' to this position (data not shown).
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inserts could be correlated with EcoRI bands of
RD(FeLV)-2 chromosomal DNA (data not
shown). By appropriate double digestions, the
flanking sequences of the different isolates could
be distinguished. We found that the 27 isolates
studied could be classified as being derived from
14 different FeLV proviruses, each with different
flanking sequences. Of the 14 proviruses, 7 were
isolated one time, 4 were isolated twice, 1 was
isolated three times, 1 was isolated four times,
and 1 was isolated five times. In some cases of
multiple isolates (Table 2), the EcoRI provirus
fragment was present in both orientations rela-
tive to the vector arms. This, along with purifi-
cation from unamplified phage libraries, was
decisive proof of independent ligation and pack-
aging.
Transfection experiments. The results of
the transfection tests with intact recombinant
phage DNA are shown in Tables 2 and 3. Of the
14 different proviruses, 4 gave positive results at
a level of 0.1 ng of cloned DNA per dish, one
gave a positive result at a level of 10 ng/dish,
and 9 were negative even at 2,000 ng/dish. Chro-
mosomal RD(FeLV)-2 DNA gave a comparable
positive response at a level of about 1,000 ng/
dish.
As a convenient and sensitive test for virus
production, we assayed for reverse transcriptase
activity in the culture fluid (30). A semiquanti-
tative dose-response comparison of different
samples was possible with the assay used (Table
3). Table 3 shows that for an infectious clone,
such as XHF60, the reverse transcriptase activity
at a given time after the addition of DNA in-
creased with the amount of DNA applied per
bottle of cells. The activity was much greater 7
weeks after transfection than 3 weeks after
transfection. The minimum infectious dose was
about 100 pg/dish for the most infectious clones.
In all tests, with several different infectious
clones, positive results were never obtained,
even 13 weeks after transfection with 10 pg of
cloned DNA per dish.
Infectivity was not diminished by EcoRI
digestion of the cloned DNA (Table 4). The
insertion from XHF60 was recloned in pBR322,
and it remained infectious (data not shown). In
the cases available for study, activity was inde-
pendent of the orientation of the viral fragment
relative to the vector arms. Identical results were
obtained after transfection onto cat cells (less
sensitive) and dog cells (more sensitive). There-
fore, these results were not due to differences in
host range. The virus obtained after transfection
with each infectious clone contained FeLV p30,
as determined by complement fixation, and was
identified as FeLV subgroup B by virus interfer-
ence tests.
TABLE 2. Transfection with segments cloned in
Charon 4A
Orienta-
Provi- Insertion tion rela- Infec-
rus length (kb) Isolt tive to tivity4
vector
1 9.5 XHF21 5-3i +b
XHF25 5'-3' +
XHF60C 5'-3' +
2d 11.2 AHF5 5'-3' +
(14.5) XHF17c 5'-3' +
3d 11.3 XHF70 NDe -
(16.5)
4 13.5 XHF62 ND -
5 13.7 XHF7 3'-5' -
XHF37 3'-5' -
6 13.9 XHF8 5'-3' -
XHF68 3'-5' -
7 14.8 XHF52c 5'-3' +
XHF67 3'-5' +




9 15.2 XHF71 ND -
10 15.6 XHF24 ND -
11 15.7 AHF40 ND +





13 18.2 XHF53 ND +
14 ND XHF31 ND -
a Assays for virus infectivity are described in Table
3, footnotes. Dog D-17 cells were used to test all DNA
samples. In addition, feline embryo fibroblast (AH927)
cells were used to test isolates XHF60, XHF52, XHF7,
XHF8, XHF49, and XHF39. For other details see Table
1, footnote a.
b For all isolates except XHF53, 100 pg of recombi-
nant phage DNA was needed to detect virus produc-
tion; for XHF53, 10 ng was needed.
c See Table 3 for an analysis of XHF60, XHF52, and
XHF17.
"Proviruses 2 and 3 had more than one EcoRI
fragment cloned into Charon 4A. The first insertion
lengths (no parentheses) are the lengths of the frag-
ments containing the FeLV genome, whereas the num-
bers in parentheses are the total lengths of the inserted
fragments.
'ND, Not determined.
Restriction endonuclease analyses. Char-
acterization of some of the cloned proviral ge-
nomes by various methods is described below;
our principal goal was to find a property that
correlated with positive or negative infectivity,
as listed in Table 2. Detailed restriction endo-
nuclease maps were deduced for the seven pro-
viruses that were obtained as multiple isolates
(Fig. 1 and 2). The enzymes used recognized 17
sites in the unintegrated viral DNA genome (29)
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TABLE 3. Transfection assaysa
Reverse transcriptase activity with the following DNA doses:C No. of
Infective weeks
recombi- after
nant cloneb 1,000 ng/cul- 100 ng/culture 10 ng/culture I ng/culture 0.1 ng/culture 0.01 ng/cul- DNAture ture treat-
ment
XHF60 2.5-3.1 (4/4)d 1.8-2.1 (6/6) 0.8-1.5 (6/6) 0.1-0.4 (4/6) Bkg (0/6)' Bkg (0/6) 3f
NT' 2.7-3.6 (6/6) 2.0-3.4 (6/6) 2.2-3.4 (6/6) 2.7-3.2 (6/6) Bkg (0/6) 7
AHF17 2.4-2.7 (2/2) 1.2-1.4 (6/6) 0.6-0.8 (6/6) 0.07-0.3 (2/6) Bkg (0/6) Bkg (0/6) 3
NT 2.6-2.9 (6/6) 2.4-3.0 (6/6) 2.5-2.8 (6/6) 2.1-2.8 (5/6) Bkg (0/6) 6
AHF52 2.1-2.0 (2/2) 1.9-2.0 (8/8) 1.1-1.5 (6/6) 0.03-0.1 (3/6) Bkg (0/6) Bkg (0/6) 3
NT 2.3-3.3 (6/6) 2.4-3.1 (6/6) 2.6-2.9 (6/6) 2.4-3.0 (5/6) Bkg (0/6) 7
a Assays were conducted as described previously (30) by using 106 dog D17 cells per assay. Virus production was measured
at 3- to 4-week intervals by the reverse transcriptase assay.
b Noninfective DNA clones were designated noninfective after they were tested at the highest dose (_1 ,ug) for the longest
time ('12 weeks).
'Reverse transcriptase assay results are reported as counts per minute (x105) of [methyl-3H]TMP incorporated per milliliter
of culture fluid (5 x 106 to 10 x 106 cells) per 60-min incubation.
dNumbers in parentheses are number of cultures positive for reverse transcriptase/number tested. Cultures scored as
negative for virus production were less than or equal to background (Bkg) in the reverse transcriptase assay. All positive cultures
were assayed by the complement fixation test for identification of viral p30 antigen. In all cases tested, p30 was FeLV. Values
for cultures considered positive by the reverse transcriptase assay were at least 20 times the background values.
'The background value for the reverse transcriptase assay was '500 cpm.
f Cultures negative for reverse transcriptase were tested for up to 11 to 13 weeks. No positive cultures were detected later
than 8 weeks after DNA treatment.
' NT, Not tested.
TABLE 4. Infectivity of cloned proviral DNAs after various treatmentsa
Infectivity after the following treatments:
Treatment of DNA before transfectionb Si nuclease digestion ofheteroduplexes'
Isolate
Gel purifi-
None EcoRI cation of Random Total 8.7-kbdigest EcoRI sheard mixture DNA
fragment
AHF60 + + + +
AHF17 + + + +








XHF7 + XHF8 + AHF49 + AHF39 -
a Assays for virus infectivity are described in Table 3, footnotes.
b All positive cultures had values of >3 x 105 cpm/ml in the reverse transcriptase assay at 4 weeks. Negative
cultures were assayed up to 16 weeks. The amounts ofDNA used per dish were 2 jig (no treatment), 2,g of each
clone (cotransfection), 1 ug (EcoRI digest), 0.2 Mug (gel-purified EcoRI fragment), and 4 ,ug (randomly sheared
DNA).
' Heteroduplexes were formed by using 2 tig of each phage DNA preparation. This total amount was testedfor infectivity for the heteroduplex between AHF7 and AHF8. The 8.7-kb DNA recovered from the gel was not
quantitated. Assuming a typical 40% recovery for this procedure, the 8.7-kb band from the heteroduplex was
positive at a 10-ng level at 9 weeks and negative at a 1-ng level. Each dilution comparable to 100, 10, or 1 ng of
material migrating with 8.7 kb after Si nuclease treatment of 4 jig of a self-renatured preparation of AHF60 was
negative even after 12 weeks.
d Duplex DNA samples were sheared by several passages through a 26-gauge syringe needle so that, as
determined by gel analysis, there was a broad distribution of lengths from about 5 to 30 kb (median, about 14
kb).
694 MULLINS ET AL. J. VIROL.
CLONED FeLV FROM A HUMAN CELL LINE 695
(one PstI site and one SmaI site were not de-
tected in our previous study). With the exception
of the heterogeneity that arose during phage
amplification (see below), these analyses did not
reveal any internal sequence differences among
the proviruses studied. As Fig. 2 shows, the sets
of bands derived from within each provirus were
identical, as determined by mobility in gel elec-
trophoresis.
The pattern of restriction endonuclease sites
within the host flanking sequences was different
for each of the 14 proviruses. Furthermore, there
was no consistent pattern of sites near the points
of provirus integration. Thus, each provirus was
integrated at a different place in the host ge-
nome, and there was no evidence for any com-
mon sequence features in these flanking se-
quences.
Repeated sequences. A prevalent set of in-
terspersed repeated sequences, designated the
Alu family, has been identified within the human
genome (20, 24). We used an available probe for
this family from a human 8-globin gene cluster
(kindly provided by E. Fritsch) (15) to search
for this sequence in the RD(FeLV) insertions
(Fig. 1 and 3). Alu family repeats were found in
two of three infectious clones and two of four
noninfectious clones. These repeats were found
both 5' and 3' to the proviral sequences. Fur-
thermore, this sequence had no detectable ho-
mology with FeLV proviral DNA.
Highly repeated sequences in the human ge-
nome (not necessarily related to the Alu family)
were mapped by using total nick-translated hu-
man RD DNA as a hybridization probe (15; T.
Sargent, personal communication). All of the
Alu family repeats were detected by this
method, and an additional repeat was mapped
to a position upstream to the provirus in XHF8.
On the average, Alu family repeats occur ap-
proximately once per 6 kb in the human genome
(20). Repeated sequence elements occur approx-
imately once per 2 kb over 50 to 60% of the
human genome (10, 39). We found at least one
repeated sequence on each of nine restriction
fragments in the 32 kb of human DNA studied,
a frequency of at least one repeat per 3.6 kb.
Thus, the frequency of repeated sequences in
the host sequences flanking the proviral ge-
nomes was about as expected for random inte-
gration. Furthermore, the position or presence
of repeated sequence elements did not correlate
in any obvious way with the infectivities of the
provirus clones studied.
Instability ofFeLV sequences in X clones.
We observed that certain phage preparations
developed heterogeneity when they were prop-
agated under relatively nonselective growth con-
ditions, such as subconfluent plate lysis, com-
pared with the more selective method of liquid
culture propagation. Heterogeneity occurred
within the eucaryotic portion of the phage, re-
sulting in minor bands either 8.2 kb larger or 8.2
kb smaller than the major band observed after
EcoRI digestion (Fig. 2, isolates 60 [XHF60] and
39 [XHF39]). Heterogeneity was observed only
in phage in which the maximum and minimum
size limits on the eucaryotic insert (22 and 8.8
kb, respectively, for Charon 4A) were not ex-
ceeded by the insertion or deletion of 8.2 kb.
Specifically, for XHF60 propagated in liquid cul-
ture, the insert was 9.5 kb long. When grown by
subconfluent plate lysis, a few phage gave an
EcoRI band 17.7 kb long. This band was weak
as determined by ethidium bromide staining but
more intense as determined by hybridization
with an FeLV probe. Similarly, when XHF39
(containing a DNA insert 17.8 kb long) was
grown by plate lysis, it produced a 9.6-kb EcoRI
band, which had an ethidium bromide intensity
about 5% of that of the 17.8-kb band. However,
this 9.6-kb band gave a very weak signal when
hybridized with an FeLV probe. (The faint band
at 10.9 kb in all of the autoradiographs of Fig.
2B was due to aX arm, as discussed in the legend
to Fig. 2.)
The length of the FeLV genome lacking one
LTR is 8.2 kb (29). Therefore, these observations
suggested that homologous site recombination
occurred between the proviral LTRs, resulting
in either a deletion (XHF39) or a tandem dupli-
cation (XHF60) of the FeLV genome. Further
restriction mapping experiments supported this
interpretation (data not shown). This interpre-
tation was confirmed by the presence of the
expected heteroduplex structures in self-rena-
tured preparations (Fig. 4). Similar recombi-
nants have been observed in X clones of the
spleen necrosis virus (33). There is no evidence
that this recombination phenomenon is related
to infectivity.
Electron microscopic heteroduplex anal-
ysis. We studied homology between proviral
sequences and the possible homologies between
host flanking sequences of the different provi-
ruses by heteroduplex analysis. Representative
structures are shown in Fig. 4, and the data are
summarized in Table 5. In all cases, an uninter-
rupted duplex region 8.8 + 0.2 kb long was
observed, corresponding to the position of the
retrovirus genome in the cloned DNA. This was
the case irrespective of whether the heterodu-
plex was between two infectious clones, between
two noninfectious clones, or between an infec-
tious clone and a noninfectious clone. We believe
that internal nonhomologies (either deletions,
insertions, or substitutions) more than about 200
base pairs long would have been observed if
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B. Eco RI digests
Isolate eetp17 7oAs1 Sue blott7 hrz5t49 39
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FIG. 2. Restriction digests ofsevenproviruc clones. Recombinantphage DNA was isolated afdescribed in
the text. Restriction digestion, gel electrophoresis, Southean blotting, hybridization, and autoradigraphy
were perfouned as described in the text and by Mullins et al (29). The left side of each panel shows the
ethidium bromide stainingpattemnafter electrophoresis in a 1.5% (A) or 0.c7r(B) agarosengel The right side
of each panel is a Southel blot of the gel on the left probed with[shPnFeLV complementary DNA rep, as
described in the text. The molecular weight markers-nin adjace t lanes were an HindIII digest of kand an
HaeIII digest ofc X174 in (A) and uncut A DNA, an EcoRI digest of Charon 4A, a Kpn digest of Charon 4A,
and a SaiI digest ofA in (B). (A) A0.375-gamount ofeach DNA sample was digested sequentiall with KpnI
and XhoI under the conditions recommended by the supplier (New England BioLabs). All isolates had five
FeLV hybridizing bands in common (at 2.8, 2.6i 1.34, 0.89, and 0.33 kb), corresponding to internal FeLV
provirus bands. Each isolate had a unique set of hybridizing firagments, corresponding to the junction of
FeLV provirus sequences and human flanking sequences. High-molecular-weight firagments (>10 kb) andlow-molecular-weight firagments(<1 kb) were underrepresented, as determined by hybridization intensity, due
to relatively poor transfer to or retention by nitrocellulose. (B) A 0.3-p amount of each DNA sample wasdigested with EcoRI and electrophoresed in a 0.7% agarose gel. Each isolate had a single EcoRI insertion,
except AHF17, which had two. The 11.2-kb insertion in XHF17, which was not resolved from the short (10.9-kb)
vector fragment in this gel, contained sequences homologous to FeLV, whereas the 3.4-kb insertion did not. A
smallpercentage ofthephage in AHF60preparations contained a duplication ofthe FeLVprovirus; a similar
percentage of the AHF39 phage had 8.2 kb of the FeLV provirus deleted. These insertions are present as
relatively faint bands on both sides of the panel at 17.7 kb (AHF60) and 9.6 kb (kHF39). The large vector
fragment (19.8 kb) and annealed vector fragments (30.7 kb) were revealed by ethidium bromide staining. Our
FeLV probe had a small amount of homology to the shorter A arm (10.9 kb), resulting in its detection by
hybridization. The -48-kb band present in the AHF7 lanes was undigested phage DNA.
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FIG. 3. Mapping ofrepeated sequence elements in the DNA flanking FeLVproviruses. A 0.75-pug amount of
DNA from each isolate was digested sequentially with HindIII, SmaI, and EcoRI by using the conditions
recommended by the supplier (New England BioLabs). The procedures used for gel electrophoresis (1.2%
agarose gel), Southern blotting, hybridization, and autoradiography were as described in the text and by
Mullins et al. (29). (A) Ethidium bromide (Eth Br) staining pattern. The molecular weight markers used were
a partial KpnI-EcoRI digest of Charon 4A DNA and an HaeIII digest of4*X174 DNA. (B) Autoradiogram of
a blot ofthe gel in (A) produced by using a nick-translated 32P-labeledAlu family repeated sequence fragment
(24) as the hybridization probe. The fragment used was the 0.45-kb TaqI-BglII fragment described by Fritsch
et al. (15), which was derived from a region 5' to the human 8-globin gene. This sequence was identified as a
member ofthe Alu family first by its homology with an Alu family repeat found elsewhere in the human /3-like
gene cluster (12, 24) and more recently by DNA sequence analysis (S. Weismann, personal communication).
Three -0.75-kb SmaI/HindIII fragments were generated by digestion of XHF49 DNA. They occurred in a
region adjacent to the 5' end of the provirus. At least two and possibly all three of these fragments contained
an Alu family repeated sequence. (C) Autoradiogram of a blot of a gel similar to that in (A) which was
hybridized by using 32P-labeled RD cellular DNA as the probe. We believe that under the conditions of
hybridization used, the repeated sequences in the probe DNA hybridized to all homologous sequences in the
cloned DNA.
present (8).
We observed there were characteristic intra-
strand secondary structure features in several of
the host flanking sequences (e.g., the hairpin
loop in XHF39) but in no case did we detect a
homology between flanking sequences.
Si nuclease analysis of heteroduplexes.
A sensitive method for searching for a mismatch
between two closely related genomes is Si nu-
clease digestion of heteroduplexes (41). Double-
stranded Si nuclease cuts can be detected by gel
electrophoresis.
Shenk and co-workers (41) found that double-
stranded cleavages are made at high frequencies
when an insertion 35 nucleotides long or longer
is present in one strand of a heteroduplex and
not in the other. Dodgson and Wells (11) found
that a mismatch of at least a 5 base pairs is
necessary for detectable cleavage.
We prepared heteroduplexes between various
A clones of the proviral sequences and treated
them with Si nuclease (see above). The diges-
tion products after native gel electrophoresis
were detected by ethidium bromide staining or
by the more sensitive method of blotting with
an FeLV probe (Fig. 5). In all analyses, the
following four bands were visible by staining: 40-
to 49-kb homoduplex molecules, vector arms
19.8 and 10.9 kb long, and an 8.7-kb provirus
band which migrated with a mobility similar to
that of unintegrated linear FeLV DNA. The
intensity of the 8.7-kb band was lower when the
proviral DNAs were in opposite orientations
relative to the vector arms (e.g., XHF7 versus
XHF60, XHF5, or XHF39) because of the lower
frequency of formation of the desired heterodu-
plexes.
Thus, within the limits of resolution of Si
nuclease digestion and neutral gel analysis, we
found no evidence for a mismatch in any of the
proviral genomes, infectious or noninfectious.
Cotransfection experiments. In the few
cases tested, it has been observed that the small
fraction of cells which are competent for the
uptake of DNA in DNA-mediated cell transfor-
















CLONED FeLV FROM A HUMAN CELL LINE 699
TABLE 5. Contour lengths of heteroduplex molecules observed by electron microscopy
Heterodu- Length (kb) No. of mol-
plex A left Sine-stranded DNA Provirus stranded DNA A right ecules
AHF39/AHF60 19.8 (0.6)' 0.9 (0.25)/0.34 (0.06) 9.0 (0.6) 6.3 (0.70)/0.4 (0.10) 11.0 (0.4) 23
AHF39/AHF52 19.7 (0.5) 1.7 (0.25)/6.2 (0.7) 8.7 (0.25) 8.2 (0.7)/0.6 (0.1) 10.9 (0.4) 38
AHF39/AHF8b 8.95 (0.04) 12
AHF7/AHF8 20.3 (0.6) 4.4 (0.25)/0.32 (0.06) 8.6 (0.1) 1.3 (0.2)/5.3 (0.45) 10.9 (0.3) 8
AHF8/AHF49 20.3 (0.6) 0.33 (0.06)/2.3 (0.2) 8.9 (0.1) 5.4 (0.5)/5.0 (0.25) 11.3 (0.3) 7
AHF60/AHF52 19.7 (0.5) 0.62 (0.08)/5.9 (0.5) 8.7 (0.5) 0.35 (0.05)/0.39 (0.05) 10.8 (0.4) 10
' The numbers in parenthees are each one standard deviation of the error.
MThis heteroduplex was constructed between two clones with the provus in opposte onentation relative to the A arms. In
the molecules measured, all of the sequences flanking the region of homology were single stranded.
a particular DNA sequence in the transforma-
tion procedure (48). Cotransfection with a num-
ber of noninfectious proviral clones could give
rise to an infectious virus if the several clones
contained mutations in viral genes which com-
plemented one another. Cotransfection with 2
utg of each of four unique noninfectious clones
failed to give rise to detectable virus (Table 4).
Transfection with sheared proviral
DNAs and SI nuclease-digested heterodu-
plexes. Cooper and Temin (7) have postulated
that inactive proviruses result from cis-acting
negative control elements in host flanking se-
quences. Cooper and Silverman (5) have re-
ported that random shearing of genomic DNA
containing a nontransfective avian provirus re-
sults in virus production when the sheared DNA
is assayed by transfection. They attributed this
phenomenon to the removal at a low frequency
of a cis-acting negative control element close to
the provirus in the genomic DNA. We performed
a similar shearing experiment, using 4 ,ig of
cloned proviral DNA (enriched in FeLV DNA
by a factor of 6 x 104 compared with uncloned
genomic DNA). Shearing so that there was a
broad distribution of molecular lengths extend-
ing from less than 5 to more than 20 kb did not
alter the infectivity status of any isolate, nor did
EcoRI digestion or gel purification of the eucar-
yotic EcoRI fragment before transfection (Table
4).
If cis-acting negative control elements were
present in the noninfectious clones, S1 nuclease
digestion of a heteroduplex would be expected
to remove them, unless they were homologous
and present immediately adjacent to the provi-
rus in the proximal few nucleotides. Conse-
quently, we analyzed S1 nuclease-treated het-
eroduplex molecule preparations for infectivity
(Table 4). Transfection with the digested heter-
oduplexes formed from 2 ,tg each of cloned DNA
from two noninfectious clones remained nonin-
fectious. A positive control experiment showing
that S1 nuclease digestion did not suppress the
transfection competence in a positive clone was
difficult because the gel-isolated 8.7-kb bands of
a heteroduplex between two infectious clones
could be contaminated with the 40- to 49-kb
homoduplex that was reformed during the hy-
bridization and nonspecifically degraded by S1
nuclease. We observed that the gel-isolated 8.7-
kb proviral band obtained after S1 nuclease
treatment of a heteroduplex between two infec-
tious clones was infectious, although at a level
approximately 100-fold lower than untreated
DNA. As a control for homoduplex contamina-
tion, we gel isolated the random, 8.7-kb frag-
ments ofDNA obtained after S1 nuclease treat-
ment of 4 ,ug of a self-renatured preparation of
an infectious clone. ThisDNA was noninfectious
(Table 4). Therefore, these data support the
hypothesis that the defect in transfection did
not reside in a negative control element imme-
diately proximal to the proviral genome.
FIG. 4. Heteroduplexes between representative clones. Portions ofrepresentative heteroduplexes are shown,
including the double-stranded provirus and the single-stranded host flanking sequences (A through C).
Cloning vector arms are not shown. The molecules are oriented such that the left A arm is to the left. Contour
length measurements for the molecules in (A) through (C) are given in Table 5. In the interpretive tracings,
thick and thin lines represent double- and single-stranded DNAs, respectively. (A) XHF52/AHF60 (infectious
with infectious). The arrows indicate single-stranded host flanking sequences. (B) XHF39/XHF60 (infectious
with noninfectious). The large arrows indicate host flanking sequences. The single strand below the hetero-
duplex was from XHF39 and shows the characteristic inverted repeat structure (small arrows). (C) XHF7/
XIF8 (noninfectious with noninfectiowus). The arrow indicates a single-stranded host flanking sequence. (D)
XHF60. Self-renatured sample showing a heteroduplex between DNA molecules with two and one copies ofthe
FeLVprovirus. (F) AHF39. Self-renatured sample showing heteroduplex between a molecule containing one
complete copy of the insertion and a molecule with an 8.2-kb deletion in the FeLVproviral sequence.
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FIG. 5. Si nuclease analysis of heteroduplexes. Heteroduplexes were formed between the recombinant
phage indicated and treated with Si nuclease as described in the text. The amount of Si nuclease and the
conditions of digestion used were such that a similar quantity of closed circular 4)174 DNA was converted
into a 1:1 mixture of nicked circular and linear mokecules. Si nuckease digests and unintegrated viral DNA
(UVD) were loaded directly onto 1.0%6 agarose gels and electrophoresed for 650 V-h. Molecular weight
markers were an HindIII digest of A DNA and an HaeIII digest of 4X147 DNA. (A) Ethidium bromide
staining pattern. In addition to material at the origin, the following four bands are visible in each lane: 40-
to 49-kb homoduplex DNA, 19.8- and 10.9-kb Charon 4A vector fragments, and a 8.7-kb FeLVprovirus band.
The slight difference in mobility observed between unintegrated linear viral DNA and proviral DNA from Si
nuclease-treated heteroduplex DNA could be attributed to salt concentration differences in the gel loading
buffer. Heteroduplexes were loaded in 0.2M sodium chloride, whereas unintegrated DNA was loaded in 0.00)6
M sodium chloride. These differences were not observed in other experiments (data not shown), in which
samples were loaded in comparabke salt concentrations. (B) Autoradiogram of a blot of the gel shown in (A)
hybridized with 32P-labeled FeLV complementary DNA. In addition to the heteroduplexes shown, similar
results were obtained with all heteroduplexes constructed and examined by Si nuclease analysis (A~HF52/
AHF60, AHF7/AHF8, XHF7/AHF49, and AHF8/AHF39).
DISCUSSION
Provirus structure and integration. With
the exception of one absent site and one new
KpnI site in the left LTR of XHF62, all of the
restriction sites that have been mapped are con-
served in all of the FeLV proviruses which we
studied and are the same as those found in
unintegrated linear viral DNA. Furthermore,
there have been no detectable insertions or dele-
tions of sequences, as judged by the electropho-
retic mobilities of the restriction fragments.
Restriction endonuclease mapping indicated
that there are a number of sites in the host
genome at which proviruses have integrated.
Restriction mapping and heteroduplex analysis
provided no evidence for any sequence homol-
ogy among these several sites. However, it
should be noted that none of the analyses per-
formed (restriction mapping, Si nuclease diges-
tion, and electron microscopic studies of heter-
oduplexes) would have detected regions of ho-
mology in the sequences immediately adjacent
to the provirus that were 100 nucleotides long or
shorter. Thus, our data do not prove whether or
not there are short regions ofsequence homology
among the various integration sites.
Members of the Alu family and one other
repeat occur in the host sequences flanking five
of the seven independent proviral isolates stud-
ied. The positions of these repeats are variable
and do not correlate with the infectivity of the
proviral DNA.
We have shown previously that the SmaI site
4.7 kb from the 5' end of the viral genome is
refractory to cleavage in about one-third of the
proviruses in RD(FeLV)-2 cells (29). Further-
more, we have found that some of the HpaII
sites in the region of this SmaI site are meth-
ylated (28a). The SmaI recognition site
(5'-CCCGGG-3') is a subset of the HpaII sites
(5'-CCGG-3'), and neither of these is cleaved if
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the underlined cytosine is methylated (16, 46).
The host bacterium in which we propagated the
recombinant phage (DP50 SupF) does not meth-
ylate cytosine at these sites. In this study we
found that none of the cloned proviruses is miss-
ing any of the four SmaI sites in the viral ge-
nome. Thus, about one-third of the proviruses
may have a SmaI-resistant site 4.7 kb from the
5' end in RD(FeLV)-2 DNA because this site is
methylated. The role of 5-methylcytosine in
gene expression has not been established defi-
nitely. The available experimental data have
demonstrated that 5-methylcytosine in the di-
nucleotide sequence CpG occurs more fre-
quently in transcriptionally inactive DNA than
in transcriptionally active DNA (34). Thus, our
data suggest that approximately one-third ofthe
proviruses in RD(FeLV)-2 cells are transcrip-
tionally inactive. However, we do not suggest
that methylation dictates infectivity of purified
DNAs since the cloned DNAs used for transfec-
tion do not contain 5-methylcytosine. It remains
to be determined whether noninfectious provi-
nises are transcriptionally inactive or specifi-
cally methylated or both in RD(FeLV)-2 cells.
Transfection. The virus produced by trans-
fection with recombinant DNA was identified as
belonging to subgroup B (Tables 1 and 2). This
was as expected, since of the two FeLV sub-
groups present (subgroups A and B) in GA-
FeLV, only subgroup B is thought to grow in
human cells (23, 38). However, recent data in-
dicate that at least two FeLV subgroup A iso-
lates grow in human RD cells (FeLV-A Glasgow-
7 and FeLV-A Rickard; M. Nicolson and 0.
Jarrett, unpublished data).
The minimum infective dose of cloned DNA
for an infectious clone is about 100 pg/dish
(about 20 pg of FeLV DNA) or 2 x 106 viral
genome copies per dish. About 1 jig of
RD(FeLV)-2 chromosomal DNA has a compa-
rable infectivity and corresponds to approxi-
mately 3 x 106 proviral genomes. Therefore, the
-infectivity per viral genome of the active cloned
DNA and the infectivity of the RD(FeLV)-2
chromosomal DNA are about the same. It is
noteworthy that 10-fold-lower doses of cloned
DNA (2 x 105 viral genome copies) have never
given a positive transfection. The reason for this
is not known.
Approxiimately two-thirds of the proviruses
isolated are not transfective at all, even at doses
10' times higher than the dose found for the
typical positive clones; thus, they appear to be
totally defective.
None of our experiments revealed any se-
quence difference between infective and nonin-
fective clones. We estimate that a region of
nonhomology, insertion, or deletion 35 nucleo-
tides long or longer or possibly shorter would
have been detected by the Si nuclease hetero-
duplex study.
The considerable background observed in the
Si nuclease experiments tended to obscure
bands formed by inefficient cleavage of short
regions of nonhomology. The use of purer prep-
arations of Si nuclease, substrates with fewer
single-stranded nicks, alkaline gel analysis, and
model substrates with known sequences of non-
homology should allow closer examination and
definition of mutations within the viral genome,
if they exist.
We observed that the 8.7-kb provirus band
produced by Si nuclease treatment of a hetero-
duplex between two infectious clones was infec-
tious, but at a level about 100-fold lower than
the level for untreated cloned DNA. One possi-
ble explanation for this is that a host sequence
which promotes virus expression may be adja-
cent to the provirus and in some molecules may
be removed by Si nuclease digestion of a het-
eroduplex. Altematively, the decrease in specific
infectivity may be due to nonspecific degrada-
tion of proviral DNA by Si nuclease.
The loss of infectivity is not an artifact of
cloning, since independent isolates for any one
provirus, as demonstrated by opposite orienta-
tions with respect to the vector and isolation
without library amplification, are either all in-
fectious or all noninfectious.
A possible mechanism of loss of infectivity is
one or several single-base changes in the viral
genome due to errors in reverse transcription
before integration or due to mutation of proviral
DNA. Altematively, Cooper and Temin (7) have
suggested that in some cases there are cis-acting
negative control elements. Our observation that
Si nuclease digestion of heteroduplexes of two
noninfectious clones does not render the heter-
oduplexes infectious argues against the latter
hypothesis in this instance. However, as de-
scribed above, we cannot exclude the possibility
that there are short regions (less than about 100
nucleotides) of sequence homology at the inte-
gration sites for the several integrated provi-
ruses. If there were two such preferred sites, one
permitting virus expression and one a negative
control element, the Si nuclease experiment
would not succeed in converting noninfectious
DNA to infectious DNA.
At present, our data do not rule out any small
differences in the LTRs found in infectious and
noninfectious clones. Obviously, further experi-
ments to determine whether the defect in virus
infection is localized to one region of the genome
and to define this defect at the sequence level
are needed.
If the defect in the provirus clones which are
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noninfectious is in some sort of a control element
and not in a structural gene, it may be that
infectivity of cloned DNA correlates with
expression at the transcriptional level of the
proviral genomes in RD(FeLV) cells. These hy-
potheses will be tested in future studies.
If there are proviral sequences which are not
expressed to produce virus in an exogenously
infected human cell line, there may be similar
nonexpressed sequences in infected cat cells.
Such sequences may play a role in the observed
lymphomas of cats that are not virus producers.
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